Solutions

Solutions

Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.

WHAT WE DO

HOW WE DO IT

Portfolio management and asset valuation
- Building patient insights into assets, profile and claims
- Portfolio optimization
- Asset valuation and indication prioritization
- Early evidence review
- Integrated development strategy and planning
Early development and innovation
- Early Phase Clinical Trials
- Site Alliance Network and KOL Engagement
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Regulatory Strategy
- Real World Evidence
- Market Access Consulting, Strategy, and Delivery
- Dedicated early phase clinical units
- Biomarker and Genomic Medicine Strategy
- Integrated evidence generation planning
- Clinical Logistics
- Medical Communications
Integrated clinical development
- Phase IIB-IV Clinical Trial Solutions
- Real World Evidence
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Protocol-Driven, Customized Site Solution Strategy
- Patient Inclusion
- Regulatory Strategy, Submissions, Compliance, and Outsourcing
- Market Access Strategy and Delivery
- Clinical Logistics
- Clinical Development Technology Optimization
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
Approval and access
- Global Regulatory Submissions and Outsourcing
- Real World Evidence
- Compliance and Risk Management
- Market Access Strategy and Delivery
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
- Health economics modelling and simulation
Value substantiation lifecycle management
- Real-World Evidence, Market Access Strategy and Planning
- Regulatory Compliance
- Lifecycle Optimization
- Integrated evidence generation planning
- Medical Communications
FSP Integrated Solutions
- Gain an advantage through FSP
Operational excellence
Medical affairs for clinical trials
Clinical study start up
ParexelAI
- Parexel and Paradigm
- Leveraging AI in clinical development

Flexible, scalable solutions.

FSP Integrated Solutions

Our FSP solutions combine talent, expertise, technology, and global scale to help sponsors increase productivity, respond to changing pipeline demands, and bring therapies to patients faster.

Biotech
Therapeutic Expertise

Therapeutic Expertise

Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

Cell and gene therapy
General medicine
- Gastroenterology CRO
- Respiratory CRO
- Endocrine & Metabolic CRO
- Cardiovascular CRO
- Women's health CRO
Infectious disease and vaccines
- Critical Care
- Hepatitis B
- Novel treatments in infectious disease
- Vaccines
Immunology
- Dermatology CRO
- Allergy CRO
Oncology CRO
- Bladder cancer CRO
- Breast cancer CRO
- Colorectal cancer CRO
- Gynecologic cancer CRO
- Head and neck cancer CRO
- Liver cancer CRO
- Lung cancer CRO
- Pancreatic cancer CRO
- Phase I oncology CRO
- Prostate cancer CRO
Neuroscience
- Neurology
- Psychiatry
Pediatrics
Rare Diseases
Hematology
- Non-malignant hematology
- Malignant hematology CRO
Ophthalmology CRO

RELATED INSIGHTS

The evidence gap in hematology: From trial endpoints to patient outcomes

Learn more

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Learn more

Insights

Insights

Our experts help you stay at the forefront of the industry — and ahead of change.

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Clinical Trialblazers

Step into the world of biotech leaders and hear the untold stories behind their journeys to bring breakthrough innovations to life.

Cell & Gene Unscripted

Honest conversations with the experts shaping what's next

Watch the series

Participate

Participate

Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.

INTERESTED IN PARTICIPATING?

TRIAL SITES

Patient volunteers
- Advisory Council
Healthy volunteers
Patient advocacy groups
Patient stories

HEAR FROM REAL PATIENTS

Patient Stories

Clinical study participation represents a deeply personal decision with potentially far-reaching impact, as evidenced by these inspiring individual stories that highlight both the life-changing potential for participants and the broader advancement of healthcare for all.

Sites
About

About

We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.

Leadership team
- Board of Directors
Global reach
Our Inclusion Strategy
Our sustainability strategy
Compliance, tax & privacy
- Compliance & Ethics
- Tax Strategy
- Privacy Policy
- Cookies and other web tracking
- Supplier Data Privacy Requirements
- Terms of Use
- French Gender Pay Data
- UK Gender Pay Data
- UK Modern Slavery Act Statement
- Ireland Gender Pay Data
- Supplier Inclusion Policy
- Vulnerability Reporting Program
Meet us at an event
- Poster presentations at EHA 2026
- Parexel Biotech Incubator

Main Menu

Solutions

Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.

WHAT WE DO

HOW WE DO IT

Portfolio management and asset valuation
- Building patient insights into assets, profile and claims
- Portfolio optimization
- Asset valuation and indication prioritization
- Early evidence review
- Integrated development strategy and planning
Early development and innovation
- Early Phase Clinical Trials
- Site Alliance Network and KOL Engagement
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Regulatory Strategy
- Real World Evidence
- Market Access Consulting, Strategy, and Delivery
- Dedicated early phase clinical units
- Biomarker and Genomic Medicine Strategy
- Integrated evidence generation planning
- Clinical Logistics
- Medical Communications
Integrated clinical development
- Phase IIB-IV Clinical Trial Solutions
- Real World Evidence
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Protocol-Driven, Customized Site Solution Strategy
- Patient Inclusion
- Regulatory Strategy, Submissions, Compliance, and Outsourcing
- Market Access Strategy and Delivery
- Clinical Logistics
- Clinical Development Technology Optimization
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
Approval and access
- Global Regulatory Submissions and Outsourcing
- Real World Evidence
- Compliance and Risk Management
- Market Access Strategy and Delivery
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
- Health economics modelling and simulation
Value substantiation lifecycle management
- Real-World Evidence, Market Access Strategy and Planning
- Regulatory Compliance
- Lifecycle Optimization
- Integrated evidence generation planning
- Medical Communications
FSP Integrated Solutions
- Gain an advantage through FSP
Operational excellence
Medical affairs for clinical trials
Clinical study start up
ParexelAI
- Parexel and Paradigm
- Leveraging AI in clinical development

Flexible, scalable solutions.

FSP Integrated Solutions

Our FSP solutions combine talent, expertise, technology, and global scale to help sponsors increase productivity, respond to changing pipeline demands, and bring therapies to patients faster.

Therapeutic Expertise

Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

Cell and gene therapy
General medicine
- Gastroenterology CRO
- Respiratory CRO
- Endocrine & Metabolic CRO
- Cardiovascular CRO
- Women's health CRO
Infectious disease and vaccines
- Critical Care
- Hepatitis B
- Novel treatments in infectious disease
- Vaccines
Immunology
- Dermatology CRO
- Allergy CRO
Oncology CRO
- Bladder cancer CRO
- Breast cancer CRO
- Colorectal cancer CRO
- Gynecologic cancer CRO
- Head and neck cancer CRO
- Liver cancer CRO
- Lung cancer CRO
- Pancreatic cancer CRO
- Phase I oncology CRO
- Prostate cancer CRO
Neuroscience
- Neurology
- Psychiatry
Pediatrics
Rare Diseases
Hematology
- Non-malignant hematology
- Malignant hematology CRO
Ophthalmology CRO

RELATED INSIGHTS

The evidence gap in hematology: From trial endpoints to patient outcomes

Learn more

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Learn more

Insights

Our experts help you stay at the forefront of the industry — and ahead of change.

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Clinical Trialblazers

Step into the world of biotech leaders and hear the untold stories behind their journeys to bring breakthrough innovations to life.

Cell & Gene Unscripted

Honest conversations with the experts shaping what's next

Watch the series

Participate

Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.

INTERESTED IN PARTICIPATING?

TRIAL SITES

Patient volunteers
- Advisory Council
Healthy volunteers
Patient advocacy groups
Patient stories

HEAR FROM REAL PATIENTS

Patient Stories

Clinical study participation represents a deeply personal decision with potentially far-reaching impact, as evidenced by these inspiring individual stories that highlight both the life-changing potential for participants and the broader advancement of healthcare for all.

About

We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.

Leadership team
- Board of Directors
Global reach
Our Inclusion Strategy
Our sustainability strategy
Compliance, tax & privacy
- Compliance & Ethics
- Tax Strategy
- Privacy Policy
- Cookies and other web tracking
- Supplier Data Privacy Requirements
- Terms of Use
- French Gender Pay Data
- UK Gender Pay Data
- UK Modern Slavery Act Statement
- Ireland Gender Pay Data
- Supplier Inclusion Policy
- Vulnerability Reporting Program
Meet us at an event
- Poster presentations at EHA 2026
- Parexel Biotech Incubator

Event

Financial Times Global Pharma and Biotech Summit 2026

November 10 - November 11, 2026

London, UK

Visit event website External link

View map External link

Add to calendar External link

Request a meeting

The Global Pharma and Biotech Summit is the essential event to explore era-defining trends and developments in healthcare and life sciences. Distinguished innovators, investors and C-Suite executives will discuss what’s new in key areas such as drug discovery, clinical trials, market access and patient engagement.

Meet out experts there!

Katie Connelly

Senior Vice President, Global Head of Regulatory Affairs

Wednesday, November 11, 1:30 – 1:50p.m.
Keynote Interview
Title: From workforce to capability: Is pharma entering a new operating model era?

Nichola Gokool

SVP, Head of Medical Communications

Tuesday, November 10, 1:30 – 2:10p.m.
Panel Session
Title: Redesigning the patient journey for better outcomes

Request a meeting

Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.